InferX Corporation Appointed Exclusive Distributor for Ontonix Analytics Technology and Products in North America
Tysons Corner, VA., July 9, 2013 – InferX Corporation (OTC/PK: NFRX) has been appointed exclusive distributor for Ontonix products, including its flagship product, OntoNet™, in North America. Ontonix has pioneered the development of innovative Quantitative Complexity Management techniques to support innovative analytics solutions. Ontonix has worked with many leading clients primarily in Italy and Europe, using its family of Quantitative Complexity Management solutions to manage risk and improve performance in the financial, healthcare, and government sectors.
The Ontonix product family will further enhance InferX’s proprietary suite of predictive analytics solutions and be offered within InferX’s upcoming Global Analytic Cloud™ portfolio of services now under development.
“I have worked with Dr. Marczyk and we see real opportunity to ‘raise the bar’, developing next gen solutions offering near real-time analytics and delivering more powerful capabilities for users, ” said Paul B. Silverman, InferX CEO and President. “We believe that coupling Ontonix’s Quantitative Complexity Management solutions with InferX’s proprietary predictive analytics solutions creates exciting new possibilities for users seeking to maximize performance and minimize risk,” said Silverman.
Ontonix and InferX will jointly target new opportunities in the financial, healthcare and government sectors. Under terms of the agreement, Ontonix will also serve as exclusive distributor for InferX products in Italy.
“Quantitative Complexity Management is an exclusive technology which has been architectured specifically for a turbulent economy, in which conventional “pre-crisis” analytics solutions are unable to produce credible results”, said Dr. J. Marczyk, the Founder and President of Ontonix. “Rapidly fluctuating complexity is a formidable crisis precursor, as has been demonstrated in our work with clients of diverse sectors, such as finance or medicine, and can be used to deliver precious early-warnings of increased vulnerability. We believe that partnering with InferX will lead to a radically innovative capability in business analytics and in particular in advanced risk management”, said Dr. J. Marczyk.
Ontonix, a privately held company established in 2005, develops award-winning, leading-edge software offering new, innovative analytics solutions to manage risk and optimize performance. The Company and its founder, Dr, Jacek Marczyk, have pioneered the creation of innovative analytic solutions in the field of Quantitative Complexity Management. OntoNet™, the company's flagship product, is a powerful, cloud-based complexity quantification and management system designed to support user applications in identifying potential crisis, securing strategic, business, and economic intelligence, and developing unique analytics metrics, such as near real-time holistic resilience ratings, to create new ways to measure resilience and how well organizations respond to change and turbulence of the global economy. Ontonix is headquarted in Como, Italy. For more information visit the company's website.
About InferX Corporation
InferX is a market leader in next generation distributed Predictive Analytics and Business Intelligence Products and Solutions. InferX has pioneered and commercialized a powerful, patented suite of advanced data analytical solutions that improve corporate performance across the enterprise in the healthcare, financial services, and government markets. The Company has two patents issued for its real time, distributed predictive analytics and business intelligence system. InferX is uniquely capable of delivering secure, real-time, and privacy preserving intelligence and decision support — all without the need to move data. InferX is headquartered in Tysons Corner, VA. For more information, visit the InferX website www.inferx.com
Certain statements above, in press releases and NFRX officials oral statements are "Forward-Looking Statements" (FLS) according to the Private Securities Litigation Reform Act of 1995 (the "Act"). FLS include statements predictive in nature, depending upon or referring to future events / conditions, including words like "believes," "anticipates," "intends," "plans," "expects," and similar expressions. Statements concerning future financial performance (revenues, earnings, and growth rates), ongoing business strategies / prospects, and future actions, which may be provided by management, are also FLS as defined by the Act. The actual and any future results, performance or achievements of the Company, expressed or implied, may be materially different and vary significantly for different reporting periods due to FLS that involve known and unknown risks and other factors. See InferX's 10-K for 12/31/11 for a discussion of those risks. Management believes that the assumptions made and expectations reflected in the FLS are reasonable. There is no assurance that the underlying assumptions will prove to be correct and the actual future results may be different from expectations expressed above. These statements are not guarantees of future performance. NFRX has no specific intention to update these statements.
©2013 InferX Corporation. All rights reserved. All trademarks and company names mentioned are the property of their respective owners.
CONTACT: InferX Corporation
Stuart T. Smith